Patient-derived xenograft (PDX) tumors increase growth rate with timeAlexander T. Pearson, Jacques E. Nör, Kristy A. Warner et al.|Oncotarget|2016Cited by 80
Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancerEmily E. Bosco, David A. Tice|Oncotarget|2018Cited by 17